Taken together, our results suggest that a lack of Fas/FasL does not protect from latent infection and virus reactivation, but due to decreased neuroinflammation, it helps to protect from neurodegeneration, although the exact mechanisms remain to be elucidated. This evidence concerns the gene FAS and disease arising from reactivation of latent virus.